These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 14051883
41. Bone marrow calcium in cancer of prostate and bladder. Megalli MR, Gursel E, Rudin L, Veenema RJ. Urology; 1973 Jul; 2(1):25-7. PubMed ID: 4128960 [No Abstract] [Full Text] [Related]
43. Bone marrow examination in carcinoma of the prostate. Nelson CM, Boatman DL, Flocks RH. J Urol; 1973 Apr; 109(4):667-70. PubMed ID: 4695110 [No Abstract] [Full Text] [Related]
44. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Schaffer DL, Pendergrass HP. Radiology; 1976 Nov; 121(2):431-4. PubMed ID: 981622 [Abstract] [Full Text] [Related]
48. [DETERMINATION OF ACID AND ALKALINE SERUM PHOSPHATASES AS A ROUTINE METHOD. II. STATISTICAL EVALUATION OF RESULTS AND THEIR CLINICAL SIGNIFICANCE]. BROCK N, HOHORST HJ, SCHNEIDER B, WILMANNS H. Arzneimittelforschung; 1964 Jul; 14():762-8. PubMed ID: 14344715 [No Abstract] [Full Text] [Related]
49. A STUDY OF THE URINARY PORPHYRINS AND PORPHYRIN PRECURSORS IN PATIENTS WITH MALIGNANT DISEASE RECEIVING DIETHYLSTILBESTROL. THEOLOGIDES A, KENNEDY BJ, WATSON CJ. Metabolism; 1964 May; 13():391-5. PubMed ID: 14169217 [No Abstract] [Full Text] [Related]
50. [A SUPPLEMENTARY REPORT ON THE SIGNIFICANCE OF MEASUREMENTS OF SERUM PHOSPHATASE ACTIVITY FOR THE DIAGNOSIS AND PROGNOSIS OF BONE TUMOR]. INADA Y. Kumamoto Igakkai Zasshi; 1963 Sep 25; 37():522-42. PubMed ID: 14090752 [No Abstract] [Full Text] [Related]
51. HYPOCALCEMIA AND HYPOPHOSPHATEMIA ACCOMPANYING OSTEOBLASTIC METASTASES. RANDALL RE, LIRENMAN DS. J Clin Endocrinol Metab; 1964 Dec 25; 24():1331-3. PubMed ID: 14243178 [No Abstract] [Full Text] [Related]
52. [Comparative evaluation of bone scanning, histological and biological studies of bone marrow in the staging of prostate cancer]. Aguirre F, Díaz González R, Leiva O, Mayor J, Borobia V. Actas Urol Esp; 1981 Dec 25; 5(2):99-104. PubMed ID: 7270287 [No Abstract] [Full Text] [Related]
53. Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase in serum with Eiken PAP RIA kit. Kida T, Higuchi Y. Oncology; 1983 Dec 25; 40(5):346-50. PubMed ID: 6621997 [Abstract] [Full Text] [Related]
54. [Activity of phosphatase in the blood serum in prostatic carcinoma depending on the stage of the tumor]. Wehnert J, Meissner D. Z Urol Nephrol; 1976 Apr 25; 69(4):243-50. PubMed ID: 952097 [No Abstract] [Full Text] [Related]
55. The use of radioactive phosphorus to treat bone pain in metastatic carcinoma of the prostate. Morales A, Burr RC, Bruce AW. Can Med Assoc J; 1970 Aug 15; 103(4):372-3. PubMed ID: 5447717 [No Abstract] [Full Text] [Related]
56. Basic diagnostic methods of clinical evaluation of the advancement of prostatic carcinoma. Ploch R. Pol Med J; 1972 Aug 15; 11(4):968-76. PubMed ID: 5078721 [No Abstract] [Full Text] [Related]
57. [APROPOS OF A PROSTATIC CARCINOMA]. BELOTTE J, GARY-BOBO J, POURQUIER H. J Radiol Electrol Med Nucl; 1964 Aug 15; 45():163-4. PubMed ID: 14143076 [No Abstract] [Full Text] [Related]
58. [ALPHA-NAPHTHYLPHOSPHATE AS A SUBSTRATE FOR MEASURING ACID PHOSPHATASE OF PROSTATIC ORIGIN]. SUEDHOF H, MEUMANN G, OLOFFS J. Dtsch Med Wochenschr; 1964 Jan 31; 89():217-9. PubMed ID: 14132259 [No Abstract] [Full Text] [Related]
59. CIRCADIAN VARIATION OF SERUM ACID PHOSPHATASE IN PROSTATIC CANCER. DOE RP, MELLINGER GT. Metabolism; 1964 May 31; 13():445-52. PubMed ID: 14169223 [No Abstract] [Full Text] [Related]
60. Alterations in serum lactate dehydrogenase and its fourth and fifth isozymes in patients with prostatic carcinoma. Prout GR, Macalalag EV, Denis LJ, Preston LW. J Urol; 1965 Oct 31; 94(4):451-61. PubMed ID: 5839576 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]